Karyopharm Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	90.85	60.54	62.48	52.23	135.19	190.46
Short-Term Investments	-	3.2	46.24	139.21	142.78	38.16
Cash & Short-Term Investments	90.85	63.74	108.71	191.44	277.97	228.62
Cash Growth	29.89%	-41.36%	-43.21%	-31.13%	21.59%	-8.28%
Accounts Receivable	23.36	26.18	30.77	26.96	47.09	22.5
Inventory	3.6	4.04	4.74	3.04	4.22	4.11
Other Current Assets	8.53	9.19	12.25	12.47	20.89	20.39
Total Current Assets	126.33	103.15	156.46	233.92	350.16	275.61
Net Property, Plant & Equipment	4.5	4.65	6.28	4.88	7.38	9.56
Other Long-Term Assets	0.58	0.62	1.67	1.64	0.63	20.14
Total Assets	131.42	108.42	164.42	240.44	358.17	305.31
Accounts Payable	4.28	4	5.11	3.12	2.77	1.6
Accrued Expenses	76.3	64.5	60.65	61.39	58.42	69.12
Current Portion of Long-Term Debt	32.23	21.01	24.43	-	-	-
Current Portion of Leases	1.02	0.97	0.44	3.31	2.87	2.32
Other Current Liabilities	3.47	1.58	1.64	1.65	1.85	0.68
Total Current Liabilities	117.3	92.06	92.26	69.48	65.91	73.72
Long-Term Debt	264.49	278.22	236.45	303.4	302.82	302.29
Long-Term Leases	5.47	5.74	6.71	2.79	6.1	8.97
Other Long-Term Liabilities	9.8	25.32	15.01	0.98	-	-
Total Long-Term Liabilities	279.76	309.28	258.17	307.17	308.92	311.26
Total Liabilities	397.06	401.34	350.44	376.64	374.83	384.98
Shareholders' Equity	-265.65	-292.93	-186.02	-136.21	-16.66	-79.67
Total Liabilities & Equity	131.42	108.42	164.42	240.44	358.17	305.31
Total Debt	303.21	305.95	268.02	309.5	311.79	313.58
Net Cash (Debt)	-212.36	-242.2	-159.31	-118.05	-33.83	-84.96
Net Cash Per Share	-14.18	-22.15	-18.84	-15.50	-6.20	-16.94
Book Value	-265.65	-292.93	-186.02	-136.21	-16.66	-79.67
Book Value Per Share	-17.74	-26.79	-22.00	-17.88	-3.05	-15.89
Tangible Book Value	-265.65	-292.93	-186.02	-136.21	-16.66	-79.67
Tangible Book Value Per Share	-17.74	-26.79	-22.00	-17.88	-3.05	-15.89

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q